Koji Takeda MD PhD
Adult Cardiac Surgery, Cardiopulmonary Transplantation, Minimally Invasive Cardiac Surgery
Assistant Professor of Surgery
177 Ft. Washington AvenueNew York, NY 10032
Overview of Dr. Takeda
Dr. Koji Takeda is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, NewYork-Presbyterian/Allen Hospital, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Osaka University Medical School and has been in practice 18 years. He is one of 147 doctors at New York-Presbyterian Hospital and one of 14 doctors at NewYork-Presbyterian/Allen Hospital who specialize in Thoracic Surgery. He also speaks multiple languages, including Japanese. He has more than 100 publications and over 500 citings.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Thoracic Surgery - Independent, 2012
Osaka University Medical SchoolClass of 1999
Certifications & Licensure
NY State Medical License 2012 - 2026
CT State Medical License 2021 - 2025
NJ State Medical License 2022 - 2025
IL State Medical License 2010 - 2012
Publications & Presentations
PubMed
- PLACE: Multicenter Study for Right Ventricular Failure on Mechanical Cardiocirculatory Supports.Valeria Lo Coco, Michele Di Mauro, Antonio Loforte, Thomas Fux, Dominik Wiedemann
ASAIO Journal. 2025-04-01 - 1 citationsClinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry.Josef Stehlik, Maryjane A Farr, Mandeep R Mehra, Jacob N Schroder, David A D'Alessandro
Circulation. 2025-04-01 - 1 citationsCurrent approaches to optimize the donor heart for transplantation.Amit H Alam, Candice Y Lee, Manreet K Kanwar, Yasbanoo Moayedi, Alexander M Bernhardt
The Journal of Heart and Lung Transplantation. 2025-04-01
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
- VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Press Mentions
The Power of MedicineMay 17th, 2023- Efficacy of Osimertinib plus Bevacizumab vs Osimertinib in Patients with EGFR T790M–Mutated Non–Small Cell Lung Cancer Previously Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase InhibitorJanuary 7th, 2021
Phase II Study of Nimotuzumab in Combination with Concurrent Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung CancerDecember 26th, 2020- Join now to see all
Professional Memberships
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
